Zomedica Corp. (ZOM) DCF Valuation
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Zomedica Corp. (ZOM) Bundle
Evaluate Zomedica Corp. (ZOM) financial outlook like an expert! This (ZOM) DCF Calculator provides pre-filled financial data along with the flexibility to modify revenue growth, WACC, margins, and other essential assumptions to align with your projections.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | .0 | .0 | 4.1 | 18.9 | 25.2 | 33.6 | 44.7 | 59.6 | 79.4 | 105.9 |
Revenue Growth, % | 0 | 0 | 0 | 358.01 | 33.05 | 33.26 | 33.26 | 33.26 | 33.26 | 33.26 |
EBITDA | -19.0 | -16.4 | -19.6 | -15.3 | -29.4 | -5.4 | -7.2 | -9.7 | -12.9 | -17.2 |
EBITDA, % | 100 | 100 | -473.51 | -81.02 | -116.68 | -16.2 | -16.2 | -16.2 | -16.2 | -16.2 |
Depreciation | .8 | .5 | 1.1 | 4.0 | 6.3 | 18.4 | 24.5 | 32.7 | 43.5 | 58.0 |
Depreciation, % | 100 | 100 | 27.57 | 21.35 | 25.01 | 54.79 | 54.79 | 54.79 | 54.79 | 54.79 |
EBIT | -19.8 | -16.9 | -20.7 | -19.4 | -35.7 | -6.7 | -8.9 | -11.9 | -15.9 | -21.2 |
EBIT, % | 100 | 100 | -501.08 | -102.38 | -141.69 | -20 | -20 | -20 | -20 | -20 |
Total Cash | .5 | 62.0 | 195.0 | 115.1 | 90.5 | 33.6 | 44.7 | 59.6 | 79.4 | 105.9 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .0 | .1 | .8 | 1.9 | 2.2 | 15.9 | 21.2 | 28.3 | 37.7 | 50.2 |
Account Receivables, % | 100 | 100 | 18.52 | 9.85 | 8.73 | 47.42 | 47.42 | 47.42 | 47.42 | 47.42 |
Inventories | .0 | .0 | 2.8 | 2.7 | 5.1 | 20.4 | 27.2 | 36.2 | 48.3 | 64.3 |
Inventories, % | 100 | 100 | 68.91 | 14.51 | 20.34 | 60.75 | 60.75 | 60.75 | 60.75 | 60.75 |
Accounts Payable | 2.1 | 1.2 | 3.2 | 6.7 | 7.7 | 23.1 | 30.8 | 41.0 | 54.6 | 72.8 |
Accounts Payable, % | 100 | 100 | 78.03 | 35.38 | 30.45 | 68.77 | 68.77 | 68.77 | 68.77 | 68.77 |
Capital Expenditure | -.7 | .0 | -.5 | -1.0 | -4.6 | -2.5 | -3.3 | -4.4 | -5.8 | -7.7 |
Capital Expenditure, % | 100 | 100 | -12.73 | -5.42 | -18.45 | -7.32 | -7.32 | -7.32 | -7.32 | -7.32 |
Tax Rate, % | 3.71 | 3.71 | 3.71 | 3.71 | 3.71 | 3.71 | 3.71 | 3.71 | 3.71 | 3.71 |
EBITAT | -19.8 | -16.9 | -18.4 | -17.0 | -34.4 | -6.3 | -8.5 | -11.3 | -15.0 | -20.0 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -17.6 | -17.4 | -19.3 | -11.5 | -34.4 | -4.0 | 8.4 | 11.2 | 14.9 | 19.8 |
WACC, % | 9.4 | 9.4 | 9.39 | 9.39 | 9.4 | 9.4 | 9.4 | 9.4 | 9.4 | 9.4 |
PV UFCF | ||||||||||
SUM PV UFCF | 34.9 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | 20 | |||||||||
Terminal Value | 273 | |||||||||
Present Terminal Value | 174 | |||||||||
Enterprise Value | 209 | |||||||||
Net Debt | -10 | |||||||||
Equity Value | 220 | |||||||||
Diluted Shares Outstanding, MM | 980 | |||||||||
Equity Value Per Share | 0.22 |
What You Will Get
- Comprehensive ZOM Financials: Access historical and projected data for precise valuation.
- Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
- Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Explore various scenarios to assess Zomedica’s future performance.
- User-Friendly Interface: Designed for professionals while remaining approachable for newcomers.
Key Features
- Comprehensive Data: Zomedica Corp.'s historical financial statements and pre-populated projections.
- Customizable Variables: Adjust inputs for WACC, tax rates, revenue growth, and EBITDA margins.
- Real-Time Insights: Monitor Zomedica's intrinsic value updates instantly.
- Visual Analytics: Dashboard graphs illustrate valuation outcomes and essential metrics.
- Designed for Precision: A professional-grade tool for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review Zomedica Corp.'s pre-filled financial data and forecasts.
- Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you adjust assumptions.
- Step 5: Analyze the results and apply the findings for your investment strategy.
Why Choose This Calculator for Zomedica Corp. (ZOM)?
- Precision: Utilizes Zomedica's actual financials for reliable data accuracy.
- Adaptability: Built to allow users to easily adjust and experiment with inputs.
- Efficiency: Eliminate the need to create a DCF model from the ground up.
- Expert-Level: Crafted with the expertise and usability of CFOs in mind.
- Intuitive: Simple to navigate, making it accessible for users without extensive financial modeling skills.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and accurate valuation models for portfolio assessment related to Zomedica Corp. (ZOM).
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within their organizations regarding Zomedica Corp. (ZOM).
- Consultants and Advisors: Offer clients precise valuation insights for investments in Zomedica Corp. (ZOM).
- Students and Educators: Utilize real-market data to practice and teach financial modeling with a focus on Zomedica Corp. (ZOM).
- Healthcare Enthusiasts: Gain insights into how companies like Zomedica Corp. (ZOM) are valued within the healthcare sector.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Zomedica Corp. (ZOM) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Zomedica Corp. (ZOM).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.